Our Company
Akrivia Health – Powering Precision Neuroscience
We are a development-stage, precision Neuroscience R & D company that focuses on delivering real-world data insights and advanced analytics to the pharmaceutical and biotech industries.
We bring together cutting-edge technology, deep clinical partnerships and real-world data to accelerate research and deliver targeted, effective treatments where they are needed most.
Why It Matters
Mental health is one of the greatest global health challenges of our time. Treatments remain too broad; progress is slow and too many patients are left behind.
At Akrivia, we’re changing that by delivering precision medicine for Mental Health.
Our Mission
To revolutionise mental health and neuroscience research through precision data, enabling faster therapeutic development and better outcomes for patients worldwide.
4 Beliefs in What We Do
- Transforming Lives Through Data and Collaboration
- At Akrivia Health, we use de-identified pathway data to speed up discovery, improve services, and deliver better care faster and at lower cost
- By collaborating globally and sharing findings openly, we drive improvements across disease areas and build trust through transparency
- Our focus on mental illness and dementia allows us to make a deeper, lasting impact where it is needed most
What We Do
- Real-World Data Platforms
Access and analyse longitudinal mental health data at scale via our proprietary platform including Akrivia CRIS - Clinical and Commercial Solutions
Partner with pharmaceuticals, CROs and biotech companies to support R&D, clinical trial optimisation and real-world evidence generation - Global Research Programmes
Lead flagship initiatives like Global Minds– a 50,000-participant precision neuroscience study combining genomics, clinical data and patient-reported outcomes - AI-Powered Insights
Use advanced analytics and healthcare-grade AI to uncover novel biomarkers, stratify patients and predict treatment response.
Join Us
Akrivia Health maintains one of the world’s largest cohorts of mental health and dementia patients, drawn from secondary care electronic health records across England and Wales. Our dataset is anonymised, harmonised and continually expanding providing an unrivalled foundation for research, innovation and clinical discovery.
Based in Oxford - Impacting the World
With roots in the UK’s world-leading research ecosystem, Akrivia Health is rapidly expanding across Europe and North America, building global partnerships to drive meaningful change in mental health and neuroscience.
